Skip to main content

Table 1 Number of study participants by study site and by study group

From: Baseline incidence of meningitis, malaria, mortality and other health outcomes in infants and young sub-Saharan African children prior to the introduction of the RTS,S/AS01E malaria vaccine

Study site Study group Number of participants (%) per study site
Kombewa, Kenya N = 4219 6 to 12 weeks 1979 (46.9)
5 to 17 months 2240 (53.1)
Kintampo, Ghana N = 7952 6 to 12 weeks 4297 (54.0)
5 to 17 months 3655 (46.0)
Navrongo, Ghana N = 2158 6 to 12 weeks 972 (45.0)
5 to 17 months 1186 (55.0)
  1. According-to-protocol cohort
  2. N, total number of study participants by study site